Monoclonal Anti-PEG Antibody, Human IgG1 (5G3-1C6)

Product Number/Spec
Price
Availability
Menge
PEG-M731-100ug
$355.00
In Stock - Delivery in 1-2 business days
PEG-M731-500ug
$1,725.00
In Stock - Delivery in 1-2 business days
PEG-M731
Product Amount :
$ 0
0
Add to Cart
New Product Suggestion Request Quote
Contact Us
Contact Us
Product Amount:
$ 0
0
Add to Cart
  • Product Details
  • Data Display
  • Reviews & Citations
  • Important Statement
  • Resources
Source

Monoclonal Anti-PEG Antibody, Human IgG1 (5G3-1C6) is recombinantly expressed in HEK293. It consists of mouse variable regions genetically fused to human constant domains.

Antibody Type

Recombinant Monoclonal

Clone

5G3-1C6

Isotype

Human IgG1, Kappa

Host Species

Mouse

Reactivity

Tag

Immunogen

PEG

Specificity

Specifically recognizes PEG.

Application
Application
Recommended Use
ELISA
0.2-2 μg/mL

* Recommended dilutions are for reference only. Optimal working concentrations may vary depending on your consumables, reagents, and assay conditions. We recommend optimizing for your specific system. No warranty is made regarding performance at any specific dilution.

Purification

Protein A purified.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 3.0) containing HAC, with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

Background Introduction

Polyethylene glycol (PEG) is a synthetic polymer widely used in pharmaceuticals as a stabilizer and excipient. PEGylation—the attachment of PEG chains to proteins or drugs—improves solubility, prolongs circulation half life, and reduces immunogenicity. Several PEGylated therapeutics, such as PEG interferon and PEG filgrastim, are already in clinical use. However, anti PEG antibodies may affect drug efficacy, making reliable detection tools essential for research and quality control.